STUDY GOALS AND OBJECTIVES
BCC’s goal in conducting this study was to determine the current status of the global therapeutic market for blood-brain barrier (BBB) technologies, including its growth potential over a 5-year period from 2010 to 2015. Our key objective was to present a comprehensive analysis of the current BBB technology and drug development market and its future direction with the aim to first define and classify that technology as it pertains to therapeutics in which the technology enables the therapeutic to directly cross rather than bypass the BBB.
REASONS FOR DOING THIS STUDY
BBB technologies are going to open up a vast untapped potential in the growing central nervous system therapeutic market where today growth is limited by the complexity of this layer in the brain that prevents the passage of many potentially useful molecules/compounds.
This report offers a picture of this technology potential that is on the verge of rapid increase. Therapeutics make up the main area of investment related to this technology; and, therefore, that is this report’s focus. BCC has not yet examined the BBB, although the central nervous system has been a consistent focus. As such, this snapshot and study of trending and growth is unique.
SCOPE OF REPORT
The scope of this study encompasses companies that develop technologies to enable the crossing of the BBB and drug development in which a quality of the development is enabling the crossing of the BBB in cases in which passage was previously impossible often due to size. BCC analyzes each technology, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next 5 years. Technological issues, including the latest trends, are discussed.
In the report, BBB technology is described in terms of what it is and its history in medicine, the types and technology categories, major companies, impact on the pharmaceutical market, applications, current market values, growth potential, and significant trends. This study will be of interest to the biotechnology and pharmaceutical industries and related life science, analytics, drug discovery, and diagnostic test manufacturing companies as well as all those interested or actively working in drug and imaging agent research and investors in all of the above.
BCC presents an analysis of the types of technologies, applications, and therapeutic areas representing financial value in the area of BBB technology in medicine as it relates primarily to drug discovery, development, and commercialization. Estimated values are based on actual aggregate sales for the years discussed. Information, in general, is compiled through a combination of primary and secondary research, including annual reports and interviews with company officials.
More CNS/Neurology reports by BCC Research
Nanomaterials in Theranostics: Global Markets by BCC Research
Nanomaterials in Theranostics: Global Markets provides:
An overview of the global market for nanomaterials in medicine used for both therapy and diagnostics, or theranostics.
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets by BCC Research
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets - This report provides:
An overview of the global market for central nervous system (CNS) biomarkers, ...
2012 Pharmaceuticals Research Review by BCC Research
This review of pharmaceutical market research provides:
Analysis and the future direction of treatments for neurodegenerative (i.e., progressive ataxia and weakness) disorders as the market ...
See all reports like this >>
Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Focus on Weakness Disorders by BCC Research
The global market for treatments for syndromes of progressive ataxia and weakness disorders was valued at nearly $14 billion in 2011 and should reach nearly ...
More Global CNS/Neurology reports
Global Amyotrophic Lateral Sclerosis Market 2014-2018 by Infiniti Research Limited - TechNavio
Global Amyotrophic Lateral Sclerosis Market 2014-2018 TechNavio's analysts forecast the Global Amyotrophic Lateral Sclerosis Drugs Market to grow at a CAGR of 5.39 percent over ...
Global Depression Drugs Market 2014-2018 by Infiniti Research Limited - TechNavio
Global Depression Drugs Market 2014-2018TechNavio's analysts forecast the Global Depression Drugs market to grow at a CAGR of 2.49 percent over the period 2013-2018. One ...
Cognitive Assessment and Training Market [Dementia Screening; Clinical Trials, Classroom Learning, Brain Training, Cognitive Abilities Test (CogAT, CAT), Concussion Management, Academic Research] Worldwide Market Forecasts and Analysis (2013-2018) by MarketsandMarkets
Cognitive Assessment and Training Market [Dementia Screening; Clinical Trials, Classroom Learning, Brain Training, Cognitive Abilities Test (CogAT, CAT), Concussion Management, Academic Research] Worldwide Market Forecasts ...
See all reports like this >>
Medulloblastoma Global Clinical Trials Review, H2, 2013 by GlobalData
Medulloblastoma Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, “Medulloblastoma Global Clinical Trials Review, H2, 2013 provides data on the Medulloblastoma clinical trial scenario. ...